- Home
- LFS vs VNRX Comparison
LFS vs VNRX Comparison
Compare LFS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFS
- VNRX
- Stock Information
- Founded
- LFS 2001
- VNRX N/A
- Country
- LFS Japan
- VNRX United States
- Employees
- LFS N/A
- VNRX N/A
- Industry
- LFS Other Consumer Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LFS Real Estate
- VNRX Health Care
- Exchange
- LFS Nasdaq
- VNRX Nasdaq
- Market Cap
- LFS 74.8M
- VNRX 69.7M
- IPO Year
- LFS 2025
- VNRX N/A
- Fundamental
- Price
- LFS $6.35
- VNRX $0.33
- Analyst Decision
- LFS
- VNRX Strong Buy
- Analyst Count
- LFS 0
- VNRX 4
- Target Price
- LFS N/A
- VNRX $3.17
- AVG Volume (30 Days)
- LFS 4.6M
- VNRX 907.7K
- Earning Date
- LFS 01-01-0001
- VNRX 11-13-2025
- Dividend Yield
- LFS N/A
- VNRX N/A
- EPS Growth
- LFS 99.16
- VNRX N/A
- EPS
- LFS 0.12
- VNRX N/A
- Revenue
- LFS $76,556,507.00
- VNRX $1,472,007.00
- Revenue This Year
- LFS N/A
- VNRX $324.32
- Revenue Next Year
- LFS N/A
- VNRX $247.82
- P/E Ratio
- LFS $41.93
- VNRX N/A
- Revenue Growth
- LFS 12.13
- VNRX 14.48
- 52 Week Low
- LFS $1.58
- VNRX $0.31
- 52 Week High
- LFS $12.49
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- LFS N/A
- VNRX 28.90
- Support Level
- LFS N/A
- VNRX $0.31
- Resistance Level
- LFS N/A
- VNRX $0.36
- Average True Range (ATR)
- LFS 0.00
- VNRX 0.04
- MACD
- LFS 0.00
- VNRX -0.00
- Stochastic Oscillator
- LFS 0.00
- VNRX 10.13
About LFS LEIFRAS Co. Ltd. American Depositary Shares
Leifras Co Ltd is a sports and social business company dedicated to youth sports and community engagement. It provide services related to the organization and operations of sports schools and sports events for children.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.